Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 91 member A1 pseudogene (FAM91A1 pseudogene) is a non-coding segment of DNA classified as a pseudogene. Pseudogenes are regions of the genome that closely resemble protein-coding genes but have lost their coding potential due to accumulated mutations, deletions, or insertions; as such, they do not produce functional proteins[1][7]. This gene does not have known physiological roles, is not considered a druggable or therapeutic target, and has no direct association with disease processes or established pharmacology[1][7][8]. Some pseudogenes elsewhere in the genome can act in regulatory networks (such as producing RNA transcripts that affect gene expression), but there is no evidence that ENSG00000225871 possesses such function at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 91 member A1 pseudogene (FAM91A1 pseudogene).